WhatsApp
backNews Article

TTK Healthcare schedules Board meeting on Nov 20, 2026 to approve Bonus Issue of NCRPS to Equity Shareholders

Trading window closure announced from November 16 to 22, 2026 for designated persons under SEBI regulations

TTK Healthcare Limited scheduled a Board meeting on November 20, 2026, to consider and approve a Scheme of Arrangement involving the issuance of Non-Convertible Redeemable Preference Shares by way of Bonus to its Equity Shareholders. The company also announced closure of the trading window from November 16 to November 22, 2026, for designated persons and their immediate relatives in compliance with SEBI regulations.

3 days ago|TTKHLTCARE+2.59%
TTK Healthcare Limited507747TTKHLTCARECorporate Action

TTK Healthcare Limited

Corporate Action

TTK Healthcare Limited informed that its Board of Directors will meet on November 20, 2026, to consider and approve a Scheme of Arrangement for issuing Non-Convertible Redeemable Preference Shares as Bonus shares to its Equity Shareholders.

The Board meeting includes consideration of the issuance under Section 230 and other applicable provisions of the Companies Act, 2013.

In line with the company’s Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in company shares will be closed from November 16 to November 22, 2026, both days inclusive, for designated persons and their immediate relatives.

This trading window closure aims to ensure compliance and integrity during the sensitive period around the announcement of the corporate action.

Highlights

  • Board meeting date set for November 20, 2026 to approve Bonus issue of Non-Convertible Redeemable Preference Shares.
  • Scheme involves issuance of shares by way of Bonus to existing Equity Shareholders.
  • Trading window closed from November 16 to November 22, 2026 for designated persons as per SEBI Code of Conduct.
  • The scheme and issuance governed under Section 230 and Companies Act, 2013 provisions.

Key Data Snapshot

Board Meeting DateNovember 20, 2026
Purpose of Board MeetingApprove issuance of Non-Convertible Redeemable Preference Shares by way of Bonus
Trading Window Closure PeriodNovember 16, 2026 to November 22, 2026 inclusive
Regulatory FrameworkSEBI (LODR) Regulations 2015, SEBI (Prohibition of Insider Trading) Regulations 2015, Companies Act 2013

What happened

  • TTK Healthcare’s Board of Directors to meet on November 20, 2026, to approve a Scheme of Arrangement involving issuance of Non-Convertible Redeemable Preference Shares (NCRPS) by way of Bonus shares to Equity Shareholders.
  • This issuance is proposed under Section 230 and other applicable provisions of the Companies Act, 2013.
  • Trading window closure is effective from November 16 to November 22, 2026, for designated persons and immediate relatives as per company’s Code of Conduct to prevent insider trading.

Regulatory and governance context

  • Announcement made pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015.
  • Trading window closure complies with SEBI (Prohibition of Insider Trading) Regulations, 2015.
  • The Scheme of Arrangement follows the Companies Act, 2013 provisions, specifically Section 230.

Next milestones

  • Board meeting on November 20, 2026, to consider and approve the Scheme of Arrangement and Bonus issuance.
  • Further disclosures expected post Board approval regarding implementation of the issuance scheme.

More News on Corporate Action

View all

Latest corporate announcements and market updates in Corporate Action.

View all news
TTK Healthcare schedules Board meeting on Nov 20, 2026 | Stockk News